SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $57,916,000 | +353.7% | 593,823 | +331.6% | 0.02% | +400.0% |
| Q4 2014 | $12,766,000 | +76.0% | 137,587 | +30.5% | 0.00% | +50.0% |
| Q3 2014 | $7,254,000 | -35.3% | 105,457 | -1.5% | 0.00% | -33.3% |
| Q2 2014 | $11,218,000 | +26.3% | 107,039 | -0.0% | 0.00% | +50.0% |
| Q1 2014 | $8,884,000 | +13.1% | 107,069 | -11.8% | 0.00% | 0.0% |
| Q4 2013 | $7,858,000 | -5.1% | 121,418 | -7.2% | 0.00% | -33.3% |
| Q3 2013 | $8,284,000 | +26.2% | 130,840 | -16.3% | 0.00% | +50.0% |
| Q2 2013 | $6,562,000 | – | 156,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|